Results 161 to 170 of about 2,252,450 (230)

Combining anti-metabolic treatments with the repurposing of eribulin for glioblastoma: a clinical opportunity? [PDF]

Transl Cancer Res
Audet-Walsh É, Galey L, Renzi S, Morin N, Hussein SMI, Richer M, Huot MÉ.   +6 more
europepmc   +1 more source

Reply to Peigneur et al. The Helix Ring Peptide U11 from the Venom of the Ant, Tetramorium bicarinatum, Acts as a Putative Pore-Forming Toxin, Not a New Kv1.3 Channel Blocker. Comment on "Boy et al. A New Kv1.3 Channel Blocker from the Venom of the Ant Tetramorium bicarinatum. Toxins 2025, 17, 379". [PDF]

Toxins (Basel)
Boy G, Jouvensal L, Téné N, Carayon JL, Bonnafé E, Paquet F, Treilhou M, Loth K, Billet A.   +8 more
europepmc   +1 more source

Recherche

Qilak, 2019
openaire   +2 more sources

Trial Watch - bispecific T cell engagers and higher-order multispecific immunotherapeutics. [PDF]

Oncoimmunology
Xue E, Deng X, Doffe F, Kroemer G, Kepp O.   +4 more
europepmc   +1 more source

Correction: DYRK1A roles in human neural progenitors. [PDF]

Front Neurosci
Courraud J, Quartier A, Drouot N, Zapata-Bodalo I, Gilet J, Benchoua A, Mandel JL, Piton A.   +7 more
europepmc   +1 more source

The A2357T substitution in the kinase domain of yeast Tor1 confers growth promoting TORC1 activity independent of Gtr1/2 and Pib2. [PDF]

Sci Rep
Dereppe C, Troch C, Saliba E, André B.
europepmc   +1 more source

Targeting SUMOylation Triggers IFN-β-dependent Activation of Patient and Allogenic NK Cells in Preclinical Models of Acute Myeloid Leukemia. [PDF]

Mol Cancer Ther
Hallal R, de Toledo M, Tempé D, Berrahouane R, Zemiti S, Coënon L, Gitenay D, George S, Schüssler M, Laguette N, Bonnet S, Gabellier L, Cartron G, Pelegrin M, Villalba M, Bossis G.   +15 more
europepmc   +1 more source

Éléments fondamentaux de la documentation du consentement à la recherche clinique au Canada : orientation stratégique. [PDF]

CMAJ
Longstaff H, Lucas B, Schichter B, Murthy S, Flamenbaum J, pour le Groupe canadien de recherche en soins intensifs.   +5 more
europepmc   +1 more source

The Use of Human Liver Chimeric Mice to Study Hepatitis C Virus Antibody Escape: Implications for Vaccine Development. [PDF]

Cell Mol Gastroenterol Hepatol
Colpitts CC, Baumert TF.
europepmc   +1 more source